Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05722886
Title DETERMINE (Determining Extended Therapeutic Indications for Existing Drugs in Rare Molecularly Defined Indications Using a National Evaluation Platform Trial) - Master Screening Protocol (DETERMINE)
Acronym DETERMINE
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Cancer Research UK
Indications
Therapies
Age Groups: adult | senior
Covered Countries GBR

Additional content available in CKB BOOST